Skip to main content
Top
Published in: BMC Women's Health 1/2016

Open Access 01-12-2016 | Research article

Biological factors that place women at risk for HIV: evidence from a large-scale clinical trial in Durban

Authors: Nathlee Samantha Abbai, Handan Wand, Gita Ramjee

Published in: BMC Women's Health | Issue 1/2016

Login to get access

Abstract

Background

It is well documented that the mucosal linings of the female genital tract (FGT) usually provides a robust barrier that protects against sexually acquired infections. However, to the best of our knowledge there are limited South African studies that have investigated the association between damage to the mucosal linings and the acquisition of HIV infections. We hypothesize that in this cohort of women, a higher rate of HIV seroconversions will be observed for women who present with evidence of mucosal damage.

Methods

We undertook a secondary analysis of the Methods for Improving Reproductive Health in Africa (MIRA) trial that assessed the effectiveness of the latex diaphragm and lubricant gel on HIV prevention among women. Participants underwent a physical examination which included a pelvic examination to detect the presence of mucosal abnormalities. During the physical examinations, the study clinicians examined the genitalia, cervix and vagina for signs of epithelial disruptions and abnormal vaginal discharge. The association between the various genital factors and HIV seroconversion was modeled using Cox proportional hazards regression analysis.

Results

In this cohort of 1485 women that had enrolled to participate in the study, women that had presented with genital epithelial disruptions and abnormal vaginal discharge were shown to be at highest risk for HIV acquisition (Hazard Ratio (HR): 4.30, 95 % CI: 2.25, 8.22, p <0001, HR: 2.37, 95 % CI: 1.69, 3.33, p <0.001) respectively. In addition, the Kaplan Meier analysis showed that the highest number of seroconversions was observed in women that had disrupted genital epithelia (27 per 100/py, 95 % CI: 15.0, 50.7) and abnormal vaginal discharge (12 per 100/py, 95 % CI: 9.70, 16.7). Other significant factors included: genital signs and symptoms (HR: 1.67, 95 % CI: 1.07, 2.61, p = 0.02) and genital ulcers/sores (HR: 1.79, 95 % CI: 1.05, 3.06, p = 0.03).

Conclusion

We have shown that damage to the mucosal epithelial lining increases a women’s risk of HIV seroconversion. Future studies that provide an in depth understanding of the mechanisms associated with the FGT and mucosal immunity will be most valuable. An understanding of all of these mechanisms will be key in directing the advancement of products most suitable for combating HIV infection in women.

Trial registration

This study was registered with ClinicalTrials.gov,number NCT00121459 on the 28th February 2007.
Literature
1.
go back to reference Abaasa A, Crook A, Gafos M, Anywaine Z, Levin J, Wandiembe S, et al. Long-term consistent use of a vaginal microbicide gel among HIV-1 sero-discordant couples in a phase III clinical trial (MDP 301) in rural south-west Uganda. Trials. 2013;14:33.CrossRefPubMedPubMedCentral Abaasa A, Crook A, Gafos M, Anywaine Z, Levin J, Wandiembe S, et al. Long-term consistent use of a vaginal microbicide gel among HIV-1 sero-discordant couples in a phase III clinical trial (MDP 301) in rural south-west Uganda. Trials. 2013;14:33.CrossRefPubMedPubMedCentral
2.
go back to reference Kaushic C, Ferreira VH, Kafka JK, Nazli A. REVIEW ARTICLE: HIV infection in the female genital tract: discrete influence of the local mucosal microenvironment. Am J Reprod Immunol. 2010;63(6):566–75.CrossRefPubMed Kaushic C, Ferreira VH, Kafka JK, Nazli A. REVIEW ARTICLE: HIV infection in the female genital tract: discrete influence of the local mucosal microenvironment. Am J Reprod Immunol. 2010;63(6):566–75.CrossRefPubMed
3.
go back to reference Hickey DK, Patel MV, Fahey JV, Wira CR. Innate and adaptive immunity at mucosal surfaces of the female reproductive tract: stratification and integration of immune protection against the transmission of sexually transmitted infections. J Reprod Immunol. 2011;88(2):185–94.CrossRefPubMedPubMedCentral Hickey DK, Patel MV, Fahey JV, Wira CR. Innate and adaptive immunity at mucosal surfaces of the female reproductive tract: stratification and integration of immune protection against the transmission of sexually transmitted infections. J Reprod Immunol. 2011;88(2):185–94.CrossRefPubMedPubMedCentral
4.
go back to reference Horbul JE, Schmechel SC, Miller BR, Rice SA, Southern PJ. Herpes simplex virus-induced epithelial damage and susceptibility to human immunodeficiency virus type 1 infection in human cervical organ culture. PLoS One. 2011;6(7), e22638.CrossRefPubMedPubMedCentral Horbul JE, Schmechel SC, Miller BR, Rice SA, Southern PJ. Herpes simplex virus-induced epithelial damage and susceptibility to human immunodeficiency virus type 1 infection in human cervical organ culture. PLoS One. 2011;6(7), e22638.CrossRefPubMedPubMedCentral
5.
go back to reference Reis Machado J, da Silva MV, Cavellani CL, dos Reis MA, Monteiro ML, Teixeira Vde P, Miranda Corrêa RR. Mucosal Immunity in the Female Genital Tract, HIV/AIDS. BioMed Research International. 2014, 2014:20. doi:10.1155/2014/350195. Reis Machado J, da Silva MV, Cavellani CL, dos Reis MA, Monteiro ML, Teixeira Vde P, Miranda Corrêa RR. Mucosal Immunity in the Female Genital Tract, HIV/AIDS. BioMed Research International. 2014, 2014:20. doi:10.​1155/​2014/​350195.
6.
go back to reference White RG. Curable sexually transmitted infection treatment interventions to prevent HIV transmission in sub-Saharan Africa. Open Infct Dis J. 2009;3:148–55.CrossRef White RG. Curable sexually transmitted infection treatment interventions to prevent HIV transmission in sub-Saharan Africa. Open Infct Dis J. 2009;3:148–55.CrossRef
7.
go back to reference Kalichman SC, Pellowski J, Turner C. Prevalence of sexually transmitted co-infections in people living with HIV/AIDS: systematic review with implications for using HIV treatments for prevention. Sex Transm Infect. 2011;87(3):183–90.CrossRefPubMedPubMedCentral Kalichman SC, Pellowski J, Turner C. Prevalence of sexually transmitted co-infections in people living with HIV/AIDS: systematic review with implications for using HIV treatments for prevention. Sex Transm Infect. 2011;87(3):183–90.CrossRefPubMedPubMedCentral
8.
go back to reference Reddy B, Rastogi S, Das B, Salhan S, Verma S, Mittal A. Cytokine expression pattern in the genital tract of chlamydia trachomatis positive infertile women—implication for T‐cell responses. Clin Exp Immunol. 2004;137(3):552–8.CrossRefPubMedPubMedCentral Reddy B, Rastogi S, Das B, Salhan S, Verma S, Mittal A. Cytokine expression pattern in the genital tract of chlamydia trachomatis positive infertile women—implication for T‐cell responses. Clin Exp Immunol. 2004;137(3):552–8.CrossRefPubMedPubMedCentral
9.
go back to reference Sperling R, Kraus TA, Ding J, Veretennikova A, Lorde-Rollins E, Singh T, et al. Differential profiles of immune mediators and in vitro HIV infectivity between endocervical and vaginal secretions from women with chlamydia trachomatis infection: a pilot study. J Reprod Immunol. 2013;99(1–2):80–7.CrossRefPubMed Sperling R, Kraus TA, Ding J, Veretennikova A, Lorde-Rollins E, Singh T, et al. Differential profiles of immune mediators and in vitro HIV infectivity between endocervical and vaginal secretions from women with chlamydia trachomatis infection: a pilot study. J Reprod Immunol. 2013;99(1–2):80–7.CrossRefPubMed
10.
go back to reference Mlisana K, Naicker N, Werner L, Roberts L, van Loggerenberg F, Baxter C, et al. Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa. J Infect Dis. 2012;206(1):6–14.CrossRefPubMedPubMedCentral Mlisana K, Naicker N, Werner L, Roberts L, van Loggerenberg F, Baxter C, et al. Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa. J Infect Dis. 2012;206(1):6–14.CrossRefPubMedPubMedCentral
11.
go back to reference Glynn JR, Biraro S, Weiss HA. Herpes simplex virus type 2: a key role in HIV incidence. Aids. 2009;23(12):1595–8.CrossRefPubMed Glynn JR, Biraro S, Weiss HA. Herpes simplex virus type 2: a key role in HIV incidence. Aids. 2009;23(12):1595–8.CrossRefPubMed
12.
go back to reference Weiss H, Buve A, Robinson N, Van Dyck E, Kahindo M, Anagonou S, et al. The epidemiology of HSV-2 infection and its association with HIV infection in four urban African populations. Aids. 2001;15:S97–S108.CrossRefPubMed Weiss H, Buve A, Robinson N, Van Dyck E, Kahindo M, Anagonou S, et al. The epidemiology of HSV-2 infection and its association with HIV infection in four urban African populations. Aids. 2001;15:S97–S108.CrossRefPubMed
13.
go back to reference Abbai NS, Wand H, Ramjee G. Socio-demographic and behavioural characteristics associated with HSV-2 sero-prevalence in high risk women in KwaZulu-Natal. BMC Research Notes. 2015;8(1):185.CrossRefPubMedPubMedCentral Abbai NS, Wand H, Ramjee G. Socio-demographic and behavioural characteristics associated with HSV-2 sero-prevalence in high risk women in KwaZulu-Natal. BMC Research Notes. 2015;8(1):185.CrossRefPubMedPubMedCentral
14.
go back to reference Burgener A, McGowan I, Klatt NR. HIV and mucosal barrier interactions: consequences for transmission and pathogenesis. Curr Opin Immunol. 2015;36:22–30.CrossRefPubMed Burgener A, McGowan I, Klatt NR. HIV and mucosal barrier interactions: consequences for transmission and pathogenesis. Curr Opin Immunol. 2015;36:22–30.CrossRefPubMed
15.
go back to reference Padian NS, van der Straten A, Ramjee G, Chipato T, de Bruyn G, Blanchard K, et al. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet. 2007;370(9583):251–61.CrossRefPubMedPubMedCentral Padian NS, van der Straten A, Ramjee G, Chipato T, de Bruyn G, Blanchard K, et al. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet. 2007;370(9583):251–61.CrossRefPubMedPubMedCentral
16.
go back to reference Moench TR, Chipato T, Padian NS. Preventing disease by protecting the cervix: the unexplored promise of internal vaginal barrier devices. Aids. 2001;15(13):1595–602.CrossRefPubMed Moench TR, Chipato T, Padian NS. Preventing disease by protecting the cervix: the unexplored promise of internal vaginal barrier devices. Aids. 2001;15(13):1595–602.CrossRefPubMed
17.
go back to reference Mesquita PM, Cheshenko N, Wilson SS, Mhatre M, Guzman E, Fakioglu E, et al. Disruption of tight junctions by cellulose sulfate facilitates HIV infection: model of microbicide safety. J Infect Dis. 2009;200(4):599–608.CrossRefPubMedPubMedCentral Mesquita PM, Cheshenko N, Wilson SS, Mhatre M, Guzman E, Fakioglu E, et al. Disruption of tight junctions by cellulose sulfate facilitates HIV infection: model of microbicide safety. J Infect Dis. 2009;200(4):599–608.CrossRefPubMedPubMedCentral
18.
go back to reference Galvin SR, Cohen MS. The role of sexually transmitted diseases in HIV transmission. Nat Rev Microbiol. 2004;2(1):33–42.CrossRefPubMed Galvin SR, Cohen MS. The role of sexually transmitted diseases in HIV transmission. Nat Rev Microbiol. 2004;2(1):33–42.CrossRefPubMed
19.
go back to reference Morse SA, Trees DL, Htun Y, Radebe F, Orle KA, Dangor Y, et al. Comparison of clinical diagnosis and standard laboratory and molecular methods for the diagnosis of genital ulcer disease in Lesotho: association with human immunodeficiency virus infection. J Infect Dis. 1997;175(3):583–9.CrossRefPubMed Morse SA, Trees DL, Htun Y, Radebe F, Orle KA, Dangor Y, et al. Comparison of clinical diagnosis and standard laboratory and molecular methods for the diagnosis of genital ulcer disease in Lesotho: association with human immunodeficiency virus infection. J Infect Dis. 1997;175(3):583–9.CrossRefPubMed
20.
21.
go back to reference Atashili J, Poole C, Ndumbe PM, Adimora AA, Smith JS. Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS (London, England). 2008;22(12):1493.CrossRef Atashili J, Poole C, Ndumbe PM, Adimora AA, Smith JS. Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS (London, England). 2008;22(12):1493.CrossRef
22.
go back to reference Greenblatt RM, Bacchetti P, Barkan S, Augenbraun M, Silver S, Delapenha R, et al. Lower genital tract infections among HIV‐infected and high‐risk uninfected women: findings of the Women's interagency HIV study (WIHS). Sex Transm Dis. 1999;26(3):143–51.CrossRefPubMed Greenblatt RM, Bacchetti P, Barkan S, Augenbraun M, Silver S, Delapenha R, et al. Lower genital tract infections among HIV‐infected and high‐risk uninfected women: findings of the Women's interagency HIV study (WIHS). Sex Transm Dis. 1999;26(3):143–51.CrossRefPubMed
23.
go back to reference Dickerson MC, Johnston J, Delea TE, White A, Andrews E. The causal role for genital ulcer disease as a risk factor for transmission of human immunodeficiency virus: an application of the Bradford hill criteria. Sex Transm Dis. 1996;23(5):429–40.CrossRefPubMed Dickerson MC, Johnston J, Delea TE, White A, Andrews E. The causal role for genital ulcer disease as a risk factor for transmission of human immunodeficiency virus: an application of the Bradford hill criteria. Sex Transm Dis. 1996;23(5):429–40.CrossRefPubMed
24.
go back to reference Røttingen J-A, Cameron DW, Garnett GP. A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known? Sex Transm Dis. 2001;28(10):579–97.CrossRefPubMed Røttingen J-A, Cameron DW, Garnett GP. A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known? Sex Transm Dis. 2001;28(10):579–97.CrossRefPubMed
25.
go back to reference Yeaman GR, Asin S, Weldon S, Demian DJ, Collins JE, Gonzalez JL, et al. Chemokine receptor expression in the human ectocervix: implications for infection by the human immunodeficiency virus‐type I. Immunology. 2004;113(4):524–33.CrossRefPubMedPubMedCentral Yeaman GR, Asin S, Weldon S, Demian DJ, Collins JE, Gonzalez JL, et al. Chemokine receptor expression in the human ectocervix: implications for infection by the human immunodeficiency virus‐type I. Immunology. 2004;113(4):524–33.CrossRefPubMedPubMedCentral
26.
go back to reference Howell AL, Asin SN, Yeaman GR, Wira CR. HIV-1 infection of the female reproductive tract. Curr HIV/AIDS Rep. 2005;2(1):35–8.CrossRefPubMed Howell AL, Asin SN, Yeaman GR, Wira CR. HIV-1 infection of the female reproductive tract. Curr HIV/AIDS Rep. 2005;2(1):35–8.CrossRefPubMed
Metadata
Title
Biological factors that place women at risk for HIV: evidence from a large-scale clinical trial in Durban
Authors
Nathlee Samantha Abbai
Handan Wand
Gita Ramjee
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Women's Health / Issue 1/2016
Electronic ISSN: 1472-6874
DOI
https://doi.org/10.1186/s12905-016-0295-5

Other articles of this Issue 1/2016

BMC Women's Health 1/2016 Go to the issue